Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-765-0 | CAS number: 7722-84-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://www.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was carried out under GLP conditions and in accordance with the OECD Guideline for Testing of Chemicals No. 474, 1994.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Hydrogen peroxide
- EC Number:
- 231-765-0
- EC Name:
- Hydrogen peroxide
- Cas Number:
- 7722-84-1
- Molecular formula:
- H2O2
- IUPAC Name:
- hydrogen peroxide
- Details on test material:
- Hydrogen peroxide, 35% w/w
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: Swiss OF1/ICO:OF1 (IOPS Caw)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Iffa Crédo, L'Arbresle, France
- Age at study initiation: approximately 6 weeks
- Weight at study initiation:
- Assigned to test groups randomly: yes
- Fasting period before study: no data
- Housing: five per sex in polycarbonate cages
- Diet (e.g. ad libitum): AO4 C pelleted diet (U.A.R., Villemoisson-sur-Orge, France) ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +/- 2
- Humidity (%): 50 +/- 20
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12 hours light/12 hours darkness
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- Water was used as the vehicle.
- Details on exposure:
- The test substance was administered once by intraperitoneal route using a dose volume of 25 mL/kg, which allowed to test higher doses with less concentrated solutions. The quantitiy of the test substance administered to each animal was adjusted according to the body weight recorded at the time of dosing. The vehicle control animals received the vehicle alone, under the same conditions. The positive control animals received cyclophosphamide, by oral routed, at a volume of 10 mL/kg.
- Duration of treatment / exposure:
- Once by intraperitoneal injection
- Frequency of treatment:
- Once
- Post exposure period:
- 24 and 48 hours
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0, 500, 1000, 2000 mg/kg body weight
Basis:
nominal in water
first cytogenetic test
- Remarks:
- Doses / Concentrations:
0, 250, 500, 1000 mg/kg body weight
Basis:
nominal in water
second cytogenetic test
- No. of animals per sex per dose:
- five males, five females
- Control animals:
- yes
- Positive control(s):
- Cyclophosphamide, administered by oral route in 10 mL/kg at a dose of 50 mg/kg body weight.
Examinations
- Tissues and cell types examined:
- For each animal, the micronuclei were counted in 20000 polychromatic erythrocytes; the polychromatic (PE) and normochromatic (NE) erythrocyte ratio was established by scoring a total of 1000 erythrocytes (PE + NE).
- Details of tissue and slide preparation:
- At the time of sacrifce, all the animals were killed after CO2 inhalation in excess. The femurs of the mice were removed and the bone marrow eluted out using fetal calf serum. After centrifugation, the supernatant was removed and the cells in the sediment were suspended by shaking. A drop of this cell suspension was placed and spread on a slide. The slides were air-dried and stained with May-Grünwald-Giemsa. All the slides were coded for scoring.
- Evaluation criteria:
- A positive response was assumed if a statistically significant increase in the number of micronucleated polychromatic erythrocytes (MPE) when compared to the vehicle group occurred, which doubled the number of MPE of the historical control data, i.e. a number greater than 3.6/1000 PE. The results were considered as negative if the above criteria was not fully met.
- Statistics:
- The mean number of MPE and the PE/NE ratio from the treated groups were compared to simultaneous vehicle groups. The inter-group comparison was performed using: for MPE the X-square test, for PE/NE ratio the Student's t-test in which p = 0.05 was used as the lowest level of significance.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The results of the second cytogenetic study are given in Table 1. The mean values of MPE of all groups treated with hydrogen peroxide were similar to those of their respective controls. A slight, statistically significant increase in the MPE number of the low-dose group after observed after 24 hours was considered as biologically insignificant, because the MPE value was within the range of historical controls, no dose-effect relationship was noted, and the increase was essentially attributed to one animal which had 13 MPE/2000 PE. The PE/NE ratio was statistically significant lower at the three doses at 24 hours and at 250 and 1000 mg/kg after 48 hours, showing that hydrogen peroxide effectively affected the bone marrow cells. The clinical signs and mortality noted in the first cytogenicity test are given in Table 2. Due to the marked mortality in the 2000 mg/kg dose group, a second cytogenetic study was carried out. In this second test, no mortality and no clinical signs were observed in the 250 and 500 mg/kg dose groups of both sexes and in the female 1000 mg/kg dose group. After treatment with 1000 mg/kg, one of sixteen males died, which was replaced by ne of the supplementary group. Hypoactivity and piloerection was noted in the other treated males at 1000 mg/kg. No macroscopic abnormalities (abdominal cavity) were seen at necropsy at doses of 250, 500 and 1000 mg/kg except for a discolourated spleen in one male at 1000 mg/kg (Table 3).
The mean values of micronucleated polychromatic erythrocytes were within the historical range in the two vehicle groups.
Cyclophosphamide induced a highly significant increase (p < 0.001) in the number of MPE. In addition, the PE/NE ratio decreased significantly (p < 0.05) showing the toxic effects of the positive control substance to bone marrow cells.
Any other information on results incl. tables
Table 1: Results of the second cytogenicity study.
Group a) |
Dose (mg/kg) |
MPE/1000 PE b) |
PE/NE ration c) |
Time of sacrifice d) (hours) |
||
Mean |
SD |
Mean |
SD |
|||
Vehicle |
- |
0.9 |
0.9 |
0.6 |
0.1 |
24 |
Test substance |
250 |
2.2** |
1.6 |
0.5* |
0.1 |
|
500 |
1.2 |
1.0 |
0.5* |
0.1 |
||
1000 |
1.6 |
1.2 |
0.5* |
0.1 |
||
Cyclophosphamide |
50 |
37.6*** |
8.2 |
0.5* |
0.1 |
|
Vehicle |
- |
1.7 |
0.8 |
0.7 |
0.2 |
48 |
Test substance |
250 |
1.9 |
0.8 |
0.5* |
0.2 |
|
500 |
1.1 |
0.5 |
0.6 |
0.1 |
||
1000 |
1.2 |
0.8 |
0.5* |
0.1 |
a) 10 animals (5 males, 5 females) per group; b) based on scoring of 2000 polychromatic erythrocytes; c) based on a total of 1000 erythrocytes (PE + NE); d) time following treatment (intraperitoneal injection, dissolved in water); MPE: micronucleated polychromatic erythrocytes; PE: polychromatic erythrocytes; NE: normochromatic erythrocytes; SD: standard deviation; * p < 0.05, ** p < 0.01, *** p < 0.001 (X-square test for MPE, Student's t-test for PE/NE ratio)
Table 2: Clinical signs and mortality noted in the frist cytogenicity study.
Dose (mg/kg) |
Time point |
Clinical signs |
Males (animals/total number of animals) |
Females (animals/total number of animals) |
500 |
2 h – 48 h |
None |
-- |
-- |
1000 |
2 h |
Piloerection |
2/10 |
0/10 |
24 h – 48 h |
None |
-- |
-- |
|
2000 |
2 h |
Convulsions before death |
5/13 |
7/13 |
2 h |
Convulsions, hypoactivity |
3/8* |
-- |
|
2 h |
Convulsions, piloerection, hypoactivity |
3/8* |
-- |
|
2 h |
Piloerection, hypoactivity |
2/8* |
1/6* |
|
2 h |
Hypoactivity |
-- |
5/6* |
|
24 h |
None |
-- |
3/6* |
|
24 h |
Mortality |
1/8* |
-- |
|
24 h |
Piloerection, hypoactivity |
5/7** |
-- |
|
24 h |
Hypoactivity |
2/7** |
3/6* |
* Animals remaining after first intraperitoneal injection; ** Animals remaining after second intraperitoneal injection
Table 3: Clinical signs and mortality noted in second cytogenic study.
Solution at 4 % hydrogen peroxide |
||||
Dose (mg/kg) |
Time point |
Clinical signs |
Males (animals/total number of animals) |
Females (animals/total number of animals) |
1000 |
2 h |
Hypoactivity |
9/16 |
-- |
2 h |
Piloerection |
3/16 |
-- |
|
2 h |
Hypoactivity, piloerection |
3/16 |
-- |
|
2 h |
Coma |
1/16 |
-- |
|
24 h |
Mortality |
1/16 |
-- |
|
24 h |
Piloerection |
15/16 |
-- |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Hydrogen peroxide did not reveal any genotoxic potential under the experimental conditions of this test. - Executive summary:
The potential of hydrogen peroxide to induce cytogenetic damage to the bone marrow cells of Swiss OF1 mice was tested in a micronucleus assay in accordance with OECD Guideline No. 474 and under GLP conditions. Preliminary toxicity tests were performed to define the doses to be used in the cytogenetic test. Six groups of 5 male and 5 female mice received the test substance by a single intraperitoneal injection at doses of 250, 500 and 1000 mg/kg. Two groups of 5 males and 5 females received the vehicle (water) alone. One group of 5 males and 5 females was treated with the positive control substance cyclophosphamide administered by a single oral dose of 50 mg/kg. For each animal, bone marrow cell smears were prepared and the micronuclei were counted in 2000 polychromatic erythrocytes. The polychromatic (PE) to normochromatic (NE) erythrocyte ratio was established by scoring 1000 erythrocytes (PE + NE). In the two vehicle control groups, the mean values of micronucleated polychromatic erythrocytes (MPE) were in the range of historical controls. Cyclophosphamide induced a highly significant increase in the number of MPE and significantly decreased the PE/NE ratio, indicating the cytotoxicity of the control substance. In all groups treated with hydrogen peroxide, the mean values of MPE were similar to those of their respective vehicle controls. A slight statistically significant increase in the MPE number in the low-dose group after 24 hours was considered as biologically insignificant. A statistically significant decrease in the PE/NE ratio in most treated groups after 24 and 48 hours showed that hydrogen peroxide effectively affected the bone marrow cells. It was concluded from the findings that under the experimental conditions hydrogen peroxide did not induce cytogenetic damage in bone marrow cells of mice when administered by the intraperitoneal route.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)